FDA expands indication for blinatumomab in treating ALL

The Food and Drug Administration has granted accelerated approval to blinatumomab for treatment of ...

Ibrutinib plus venetoclax is active in mantle cell lymphoma

FROM THE NEW ENGLAND JOURNAL OF MEDICINE In mantle cell lymphoma (MCL), ibrutinib plus ...

CBC data can predict immunotherapy responses in NSCLC

REPORTING FROM THE NCCN ANNUAL CONFERENCE ORLANDO (FRONTLINE MEDICAL NEWS) – Information readily available ...